Third of a series of letters regarding the implementation of the Act

Issue Date: March 2, 1998
Issued by: Center for Drug Evaluation and Research
Topic(s): Generic Drugs
Status: Final

Third of a series of letters regarding the implementation of the Act

This is the third in a series of letters intended to inform you of policy and procedure developments with respect to the implementation of the Drug Price Competition and Patent Restoration Act of 1984.

Download the Guidance Document

webmaster1998-03-02T00:00:00+00:00

ABOUT US

Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant analytical and bioanalytical services to support drug development. From early discovery through clinical development and commercialization, we provide CGMP and GLP-compliant services tailored to your therapeutic modality and regulatory needs.